Share Search
Visit the Share Search
Life Science Accounts Summary
| Date of Accounts | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Standard | IFRS | IFRS | IFRS | IFRS | |
| Millions | Millions | Millions | Millions | ||
| Income Statement | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 | |
| Revenue | 20.31 | 19.94 | 15.71 | 0.53 | |
| Operating Profit / Loss | -7.79 | -14.59 | -26.94 | 7.73 | |
| Net Interest | -6.19 | -7.26 | -0.53 | 0.01 | |
| Pre Tax Profit | -13.98 | -21.85 | -27.47 | 7.74 | |
| Post Tax Profit | -13.98 | -21.71 | -27.61 | 7.74 | |
| Profit for the Period | -13.98 | -21.71 | -27.61 | 7.74 | |
| Equity Holders of Parent Company | -13.98 | -21.71 | -27.61 | 7.74 | |
| Minority Interests | n/a | n/a | n/a | n/a | |
| Continuing EPS | |||||
| Earnings per Share (Basic) | -4.00p | -6.20p | -7.90p | 2.20p | |
| Earnings per Share (Diluted) | -4.00p | -6.20p | -7.90p | 2.20p | |
| Earnings per Share (Adjusted) | 1.70p | 1.90p | 0.70p | -0.10p | |
| Continuing and Discontinued EPS | |||||
| Earnings per Share (Basic) | -4.00p | -6.20p | -7.90p | 2.20p | |
| Earnings per Share (Diluted) | -4.00p | -6.20p | -7.90p | 2.20p | |
| Earnings per Share (Adjusted) | 1.70p | 1.90p | 0.70p | -0.10p | |
| Dividend per Share | 1.00p | 2.00p | 4.00p | n/ap | |
| Millions | Millions | Millions | Millions | ||
| Balance Sheet | 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 | |
| Non-Current Assets | |||||
| Intangible Assets | n/a | n/a | n/a | n/a | |
| Property, Plant and Equipment | n/a | n/a | n/a | n/a | |
| Investments | n/a | n/a | n/a | n/a | |
| Investment Properties | 385.22 | 382.30 | 387.55 | 192.17 | |
| Other Financial Assets | n/a | 4.00 | 3.87 | n/a | |
| Other Non-Current Assets | 3.83 | 3.41 | 2.70 | n/a | |
| Total Non-Current Assets | 389.05 | 389.71 | 394.12 | 192.17 | |
| Current Assets | |||||
| Inventories | n/a | n/a | n/a | n/a | |
| Trade and Other Receivables | 4.20 | 6.66 | 7.66 | 3.27 | |
| Cash at Bank and in Hand | 5.57 | 14.34 | 45.61 | 165.96 | |
| Current Asset Investments | n/a | n/a | n/a | n/a | |
| Other Current Assets | 2.38 | n/a | 0.43 | n/a | |
| Total Current Assets | 12.14 | 21.00 | 53.70 | 169.23 | |
| Other Assets | n/a | n/a | n/a | n/a | |
| Total Assets | 401.19 | 410.70 | 447.83 | 361.40 | |
| Current Liabilities | |||||
| Borrowings | n/a | n/a | 35.74 | n/a | |
| Other Current Liabilities | 12.36 | 14.44 | 14.70 | 10.82 | |
| Total Current Liabilities | 12.35 | 14.44 | 50.44 | 10.82 | |
| Net Current Assets | n/a | n/a | n/a | n/a | |
| Non-Current Liabilities | |||||
| Borrowings | 122.24 | 107.92 | 74.09 | n/a | |
| Provisions | n/a | n/a | n/a | n/a | |
| Other Non-Current Liabilities | 3.83 | 4.60 | 3.84 | n/a | |
| Total Non-Current Liabilities | 126.06 | 112.52 | 77.93 | n/a | |
| Net Assets | 262.77 | 283.75 | 319.45 | 350.58 | |
| Capital and Reserves | |||||
| Share Capital | 3.50 | 3.50 | 3.50 | 3.50 | |
| Share Premium Account | n/a | n/a | n/a | 339.34 | |
| Other Reserves | 314.82 | 321.82 | 335.82 | n/a | |
| Retained Earnings | -55.55 | -41.58 | -19.87 | 7.74 | |
| Shareholders Funds | 262.77 | 283.75 | 319.45 | 350.58 | |
| Minority Interests / Other Equity | n/a | n/a | n/a | n/a | |
| Total Equity | 262.77 | 283.75 | 319.45 | 350.58 | |
| 31-12-2024 | 31-12-2023 | 31-12-2022 | 31-12-2021 | ||
| Operating Margin | -38.36% | -73.16% | -171.53% | 1,453.76% | |
| Return on Capital Employed | -2.02% | -3.72% | -6.28% | 2.21% | |
| Dividend Cover | 1.70 | 0.95 | 0.17 | n/a | |
| Dividend Yield | 2.60 | 3.20 | 5.50 | n/a | |
| PE Ratio | 22.40 | 33.30 | 103.30 | n/a | |
| PEG | n/a | 0.20 | n/a | n/a | |
| Dividend per Share Growth | -50.00% | -50.00% | n/a% | n/a% | |
| Net Asset Value per Share | 75.08p | 81.07p | 91.27p | 100.17p |